Dolutegravir Expanded Access Study

NCT01536873 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Human Immunodeficiency Virus
HIV Infections

Interventions

DRUG: Dolutegravir

Sponsor

ViiV Healthcare

Collaborators

[object Object]